MedPath

ebulized Budesonide and spirometric indexes in Chronic Obstructive Pulmonary Disease exacerbatio

Phase 3
Recruiting
Conditions
Chronic obstructive pulmonary disease exacerbation.
Chronic obstructive pulmonary disease with (acute) exacerbation
Registration Number
IRCT20170808035565N3
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
47
Inclusion Criteria

COPD exacerbation patients
FEV1/FVC less than 70%
No need for ventilator

Exclusion Criteria

FEV1 Increase greater than 200 cc or 12% after salbutamol administration in spirometry
The history of infectious diseases such as tuberculosis, recent respiratory infections, bronchiectasis and acute or chronic diarrhea
Probability of malignancy based on examination
Rheumatic arthritis, degenerative joint disease, vasculitis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath